Answer
There is insufficient evidence to exclude risk to the infant. Discuss treatment need, infant factors and breastfeeding benefits with the oncology team before deciding.
Sources for this answer
- NEULASTA Pre-Filled Syringe — Current selected SmPCemc · Summary of Product Characteristics
- NHS Specialist Pharmacy ServiceNHS Specialist Pharmacy Service · NHS medicine guidance
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.